[1]
“LIPOSOMAL GELS AS CARRIERS FOR SAFER TOPICAL DELIVERY OF TAZAROTENE”, Pharmaceutical sciences, vol. 3, no. 12, Jan. 2014, Accessed: Oct. 23, 2026. [Online]. Available: http://www.innovativejournal.in/index.php/jpro/article/view/580